| Basics |
|
Edesa Biotech, Inc.
|
| IPO Date: |
June 25, 2010 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$12.92M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.15 | 3.80%
|
| Avg Daily Range (30 D): |
$0.05 | 2.62%
|
| Avg Daily Range (90 D): |
$0.06 | 2.56%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.33M |
| Avg Daily Volume (30 D): |
.39M |
| Avg Daily Volume (90 D): |
.16M |
| Trade Size |
| Avg Trade Size (Sh.): |
158 |
| Avg Trade Size (Sh.) (30 D): |
87 |
| Avg Trade Size (Sh.) (90 D): |
92 |
| Institutional Trades |
| Total Inst.Trades: |
11 |
| Avg Inst. Trade: |
$1.16M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.24
|
$-.25
|
$-.3
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$
|
$
|
$
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -5.92M
|
$ -1.75M
|
$ -1.59M
|
|
Operating Income / Loss
|
$ -6.45M
|
$ -1.9M
|
$ -1.64M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ M
|
$ M
|
$
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 11, 2023:
1:7
|
|
Jun 10, 2019:
1:6
|
|
May 07, 2018:
1:7
|
|
Sep 02, 2015:
1:10
|
|
|
|